US Market Report for Prostate Cancer Treatment Devices 2016

  • ID: 3774287
  • Report
  • Region: United States
  • 81 pages
  • iData Research
1 of 5
Unlike other cancer treatments, brachytherapy has a history that spans over a century. In 1901, Pierre Curie, a physicist from France, first suggested that radiation could be used to treat cancer to one of his colleagues, a doctor named Henri-Alexandre Danlos. Dr. Danlos tested the idea and found that radiation caused tumors to shrink. Early techniques of brachytherapy were first performed at the Curie institute by Dr. Danlos. Over the next fifty years, doctors around the globe (through trial and error) expanded clinical applications of brachytherapy to include cervical, prostate and breast.

Towards the end of the 20th century, brachytherapy received a huge stimulation from imaging technologies such as magnetic resonance imaging (MRI), computer tomography (CT) and ultrasound. This allowed doctors to place the radioactive materials in precise locations in the body. RTi may be broken down into permanent and temporary modalities.

Cryoablation is the use of freezing temperatures to erode and destroy specific tissue cells. What is known as modern cryoablation therapy began in the early 1960s when cryosurgical probes cooled by liquid nitrogen were introduced. In the 1970s, handheld cryoablation devices were developed for cardiac purposes. As time went on, cryoablation has evolved into an exact science. Modern cryoablation can be described in four stages: freeze, thaw, hemorrhage and inflammation and replacement fibrosis. The theory claims that, during the initial phase, the cellular metabolism of the tissue is slowed and the area experiences progressive hypothermia. Once the thaw begins, the tissue experiences cellular damage, which culminates in vascular obliteration and ischemic cellular necrosis. Cryoablation uses compressed argon gas as a coolant. As the gas progresses through the needle, the end of the needle develops an ice ball that is then used to “ablate” the desired tissue.

The market for cryoablation is a little bit different from other ablations. Of all procedures performed in 2015, half of them originated from capital units that were already installed and the other half came from rentals. As such, the cryoablation models in this chapter are split into rentals (which include disposables), disposables used by an existing installed base and the machines themselves. When a hospital needs to perform a cryo procedure that does not own the capital equipment, they can have it dropped off (complete with the disposables) for a fee. For hospitals that do not have the funds or lack a sufficient customer base, this arrangement can be desirable.
READ MORE
Note: Product cover images may vary from those shown
2 of 5
Table Of Contents I
List Of Figures Iii
List Of Charts V
Executive Summary
1.1 U.S. Urological Device Market Overview
1.2 Competitive Analysis
1.3 Market Trends
1.4 Markets Included
1.5 Procedure Numbers
1.6 Procedure Codes Investigated
1.7 Market Developments
1.8 Key Report Updates
1.9 Version History
Research Methodology
2.1 Research Scope
2.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
Prostate Cancer Treatment Device Market
3.1 Introduction
3.2 Market Overview
3.3 Market Analysis And Forecast
3.3.1 Total Brachytherapy Device Market
3.3.1.1 Total HDR Brachytherapy Market
3.3.1.1.1 Afterloader Market
3.3.1.1.2 Afterloader Service Market
3.3.1.2 Total LDR Brachytherapy Market
3.3.1.2.1 Total LDR Seed Market
3.3.1.2.2 LDR Needle Market
3.3.2 Total Cryoablation Market
3.3.2.1 Cryotherapy Ablation Device Market
3.3.2.2 Cryotherapy Ablation Device Rental Market
3.3.2.3 Cryotherapy Ablation Probe Market
3.4 Drivers And Limiters
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 Competitive Analysis
3.5.2 Prostate Cancer Treatment Device Market
3.5.3 Brachytherapy Device Market
3.5.4 Cryotherapy Ablation Device Market
Abbreviations

Chart 1 1: Urological Device Market by Segment, U.S., 2012 – 2022

Chart 1 2: Urological Device Market Overview, 2015 and 2022

Chart 3 1: Prostate Cancer Treatment Device Market by Type, U.S., 2012 – 2022

Chart 3 2: Prostate Cancer Treatment Device Market Breakdown, U.S., 2015

Chart 3 3: Prostate Cancer Treatment Device Market Breakdown, U.S., 2022

Chart 3 4: Brachytherapy Device Market by Type, U.S., 2012 – 2022

Chart 3 5: HDR Brachytherapy Market by Segment, U.S., 2012 – 2022

Chart 3 6: Afterloader Market, U.S., 2012 – 2022

Chart 3 7: Afterloader Service Market, U.S., 2012 – 2022

Chart 3 8: LDR Brachytherapy Market by Segment, U.S., 2012 – 2022

Chart 3 9: Total LDR Seed Market, U.S., 2012 – 2022

Chart 3 10: LDR Seed Market by Type, U.S., 2012 – 2022

Chart 3 11: Total Cs-131 Market, U.S., 2012 – 2022

Chart 3 12: Stranded Cs-131 Market, U.S., 2012 – 2022

Chart 3 13: Non-Stranded Cs-131 Market, U.S., 2012 – 2022

Chart 3 14: Total Pd-103 Market, U.S., 2012 – 2022

Chart 3 15: Stranded Pd-103 Market, U.S., 2012 – 2022

Chart 3 16: Non-Stranded Pd-103 Market, U.S., 2012 – 2022

Chart 3 17: Total I-125 Market, U.S., 2012 – 2022

Chart 3 18: Stranded I-125 Market, U.S., 2012 – 2022

Chart 3 19: Non-Stranded I-125 Market, U.S., 2012 – 2022

Chart 3 20: LDR Needle Market, U.S., 2012 – 2022

Chart 3 21: Cryotherapy Ablation Market by Segment, U.S., 2012 – 2022

Chart 3 22: Cryotherapy Ablation Device Market, U.S., 2012 – 2022

Chart 3 23: Cryotherapy Ablation Device Rental Market, U.S., 2012 – 2022

Chart 3 24: Cryotherapy Ablation Probe Market, U.S., 2012 – 2022

Chart 3 25: Leading Competitors, Prostate Cancer Treatment Device Market, U.S., 2015

Chart 3 26: Leading Competitors, Brachytherapy Device Market, U.S., 2015

Chart 3 27: Leading Competitors, Cryotherapy Ablation Device Market, U.S., 2015

Figure 1 1: Urological Devices Competitor Market Share Ranking by Segment, U.S., 2015 (1 of 2)

Figure 1 2: Urological Devices Competitor Market Share Ranking by Segment, U.S., 2015 (2 of 2)

Figure 1 3: Companies Researched in this Report, U.S., 2015

Figure 1 4: Factors Impacting the Urological Device Market by Segment, U.S. (1 of 2)

Figure 1 5: Factors Impacting the Urological Device Market by Segment, U.S. (2 of 2)

Figure 1 6: Urological Markets Covered, U.S., 2015 (1 of 5)

Figure 1 7: Urological Markets Covered, U.S., 2015 (2 of 5)

Figure 1 8: Urological Markets Covered, U.S., 2015 (3 of 5)

Figure 1 9: Urological Markets Covered, U.S., 2015 (4 of 5)

Figure 1 10: Urological Markets Covered, U.S., 2015 (5 of 5)

Figure 1 11: Urological Procedures Covered, U.S., 2015 (1 of 2)

Figure 1 12: Urological Procedures Covered, U.S., 2015 (2 of 2)

Figure 1 13: Procedural Codes Investigated, U.S., 2015

Figure 1 14: Recent Events in the Urological Device Market, U.S., 2012 - 2015

Figure 1 15: Key Report Updates

Figure 1 16: Version History

Figure 3 1: Prostate Cancer Treatment Device Market by Type, U.S., 2012 – 2022 (US$M)

Figure 3 2: Brachytherapy Device Market by Type, U.S., 2012 – 2022 (US$M)

Figure 3 3: HDR Brachytherapy Market by Segment, U.S., 2012 – 2022

Figure 3 4: Afterloader Market, U.S., 2012 – 2022

Figure 3 5: Afterloader Service Market, U.S., 2012 – 2022

Figure 3 6: LDR Brachytherapy Market by Segment, U.S., 2012 – 2022

Figure 3 7: Total LDR Seed Market, U.S., 2012 – 2022

Figure 3 8: LDR Seed Market by Type, U.S., 2012 – 2022 (US$M)

Figure 3 9: Total Cs-131 Market, U.S., 2012 – 2022

Figure 3 10: Stranded Cs-131 Market, U.S., 2012 – 2022

Figure 3 11: Non-Stranded Cs-131 Market, U.S., 2012 – 2022

Figure 3 12: Total Pd-103 Market, U.S., 2012 – 2022

Figure 3 13: Stranded Pd-103 Market, U.S., 2012 – 2022

Figure 3 14: Non-Stranded Pd-103 Market, U.S., 2012 – 2022

Figure 3 15: Total I-125 Market, U.S., 2012 – 2022

Figure 3 16: Stranded I-125 Market, U.S., 2012 – 2022

Figure 3 17: Non-Stranded I-125 Market, U.S., 2012 – 2022

Figure 3 18: LDR Needle Market, U.S., 2012 – 2022

Figure 3 19: Cryotherapy Ablation Market by Segment, U.S., 2012 – 2022 (US$M)

Figure 3 20: Cryotherapy Ablation Device Market, U.S., 2012 – 2022

Figure 3 21: Cryotherapy Ablation Device Rental Market, U.S., 2012 – 2022

Figure 3 22: Cryotherapy Ablation Probe Market, U.S., 2012 – 2022

Figure 3 23: Drivers and Limiters, Prostate Cancer Treatment Device Market, U.S., 2015

Figure 3 24: Leading Competitors, Prostate Cancer Treatment Device Market, U.S., 2015

Figure 3 25: Leading Competitors, Brachytherapy Device Market, U.S., 2015

Figure 3 26: Leading Competitors, Cryotherapy Ablation Device Market, U.S., 2015
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Internal radiation therapy (RTi), also known as brachytherapy, is a form or RT that puts the radioactive material inside the patient either via a catheter or a needle. In terms of its placement, RTi may be administered as intracavitary or interstitial. In the case of intracavitary, the radioactive material is placed inside a cavity in the body such as in the rectum or uterus; in the case of interstitial, the radioactive material is placed on/near the cancer but not inside a body cavity. The most common form of brachytherapy involves the placement of “seeds” inside the body involving differing durations and radioactivity. Each seed is approximately the size and shape of a small grain of rice.
Note: Product cover images may vary from those shown
5 of 5
Galil Medical
HealthTronics
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll